Mason Michael 4
4 · Karyopharm Therapeutics Inc. · Filed Feb 8, 2023
Insider Transaction Report
Form 4
Mason Michael
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2023-02-06$3.40/sh−4,141$14,079→ 164,368 total
Footnotes (1)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.